Signature Entertainment Secures U.K. and Irish Rights for ‘The Cure’
Signature Entertainment has acquired the U.K. and Irish rights to the upcoming psychological horror film, The Cure, produced by Vaneast Pictures. This deal was confirmed by The Hollywood Reporter, marking a significant step for the film ahead of its anticipated release.
Set to captivate audiences, The Cure follows 16-year-old Ally Braun, portrayed by Samantha Cochran, who unravels disturbing truths about her adoptive parents, wealthy biotech entrepreneurs. The film features notable performances from David Dastmalchian and Ashley Greene, adding to its appeal.
Behind the Production
The film is produced by a team including John Ierardi, Nancy Leopardi, and Bo Youngblood, with executive production by Danielle Gasher. Written by Jonathan Bernstein and James Greer, both known for their work on Unsane, the film is directed by Nancy Leopardi, known for Nanny Cam.
In discussing the acquisition, Max Hart, Signature Entertainment’s acquisitions executive, expressed enthusiasm about the film’s potential. He stated, “The Cure puts a sharp, high-concept twist on classic psychological horror, led by a truly chilling duo in David Dastmalchian and Ashley Greene. It’s exactly the kind of smart, elevated genre that we champion at Signature, and we’re excited to give U.K. and Irish audiences the medicine they need next year.”
Vaneast Pictures’ founder, Danielle Gasher, also shared her excitement about the partnership. “Vaneast is thrilled to be partnering with Signature, whose reputation for delivering bold, high-quality genre films makes them a natural fit for The Cure. The film has found an excellent home in the U.K. and Ireland, and we couldn’t imagine a better partner to bring this chilling story to audiences.”
Future Prospects
The acquisition signals a strong interest in psychological horror films within the U.K. and Irish markets, particularly those that push creative boundaries. With its compelling narrative and talented cast, The Cure is well-positioned for success when it is released next year. As the film industry continues to evolve, projects like this exemplify the blend of innovative storytelling and high-caliber talent that drives audience engagement.
As anticipation builds, fans of the genre can look forward to witnessing how The Cure unfolds, with its unique take on horror that promises to resonate with viewers seeking more than traditional scares.
